People with schizophrenia often walk excessively for several overlapping reasons, and the most common one may surprise you: it’s frequently a side effect of their medication rather than a symptom of the illness itself. That said, the disease and the drugs used to treat it can both drive compulsive pacing, and telling the two apart is one of the trickier problems in psychiatric care. Understanding what’s behind the walking matters, because the causes point to very different solutions.
Akathisia: The Medication-Driven Urge to Move
The single biggest reason people with schizophrenia pace, rock, or walk for hours is a condition called akathisia. It’s a side effect of antipsychotic medications, and it affects roughly 14% to 35% of people taking them. Akathisia creates an intense, almost unbearable internal restlessness that makes sitting still feel physically impossible. People describe it not as wanting to walk, but as needing to, the way you’d need to scratch an itch that won’t go away.
The mechanism involves how antipsychotic drugs work in the brain. These medications reduce psychotic symptoms by blocking a specific type of dopamine receptor in the brain’s movement-coordination centers. That same blockade disrupts the normal signaling that lets you feel comfortable at rest. Older antipsychotics, which block dopamine receptors more aggressively, carry a much higher risk. One large comparison found that certain older antipsychotics were up to 24 times more likely to cause akathisia than newer alternatives. Even the newer drugs aren’t risk-free, though. The lowest-risk newer antipsychotic still nearly doubled the odds compared to a placebo.
Akathisia typically develops within the first two weeks of starting a new antipsychotic or increasing the dose. The walking it produces has a distinctive quality: continuous pacing, shifting weight from foot to foot, an inability to stay seated. People with akathisia are usually aware that something feels wrong. They can articulate the inner tension driving their movement, even if they can’t stop it. This subjective distress is a key feature, and it’s part of what makes akathisia so harmful. Left untreated, it’s associated with increased risk of suicide and a higher likelihood that people will stop taking their medication altogether.
Psychomotor Agitation From the Illness Itself
Schizophrenia can also drive excessive movement independent of any medication. Psychomotor agitation is a core feature of acute psychotic episodes, defined by increased motor activity paired with inner tension and heightened reactivity to both internal and external stimuli. The walking this produces tends to look different from akathisia. It’s often more erratic, accompanied by fidgeting, hand-wringing, pulling at clothes, and an overall inability to hold still.
What fuels this kind of movement is the psychosis itself. Someone experiencing persecutory delusions (the belief that they’re being followed or threatened) may walk compulsively because they feel unsafe staying in one place. Command hallucinations, where voices tell the person to do something, can also drive repetitive walking. In these cases, the movement has an emotional logic even when it looks purposeless from the outside. The person is responding to a perceived threat or instruction that feels completely real to them.
Psychomotor agitation tends to come and go with the severity of psychotic symptoms. It’s most visible during acute episodes and often settles as the person stabilizes. This pattern is one of the ways clinicians try to distinguish it from medication side effects, though the two frequently overlap in the same person at the same time.
Stereotypies: Repetitive Walking as a Motor Pattern
A third contributor is a phenomenon called stereotypy, which refers to repetitive, unvarying motor behavior that serves no obvious function. In schizophrenia, stereotypies can include pacing the same route over and over, walking in circles, or retracing a fixed path for extended periods. Unlike agitation-driven walking, stereotypic walking tends to be calm and rhythmic. The person doesn’t appear distressed. They simply repeat the same movement pattern without clear purpose or variation.
Researchers believe stereotypies arise from a breakdown in the brain’s ability to inhibit automatic motor responses. Normally, your brain constantly suppresses repetitive movement impulses so you can shift attention and behavior flexibly. When that inhibitory system malfunctions, preprogrammed motor patterns like walking can loop without a natural stopping point. This kind of repetitive walking is more common in people with long-standing schizophrenia and often coexists with other repetitive behaviors.
Why These Causes Are Easy to Confuse
One of the most significant problems in managing excessive walking in schizophrenia is that akathisia, psychomotor agitation, and stereotypies can look nearly identical from the outside. A person pacing a hallway could be doing so because their medication is making them restless, because voices are telling them to move, or because their brain is stuck in a repetitive loop. The treatment for each is different, and getting it wrong can make the problem worse.
Akathisia is frequently misdiagnosed as worsening psychosis. When that happens, the clinical response is often to increase the antipsychotic dose, which actually intensifies the restlessness. This creates a vicious cycle where the person paces more, appears more agitated, receives more medication, and deteriorates further. Timing is one useful clue: if the walking started or worsened shortly after a medication change, akathisia is the most likely explanation. If it tracks with the severity of hallucinations or delusions, psychomotor agitation is more probable.
The person’s own experience also helps. Someone with akathisia can usually describe the uncomfortable inner sensation driving their movement. Someone in a psychotic episode may not recognize the pacing as unusual at all, or may explain it in terms of their delusions.
How Medication-Induced Pacing Is Managed
When akathisia is identified as the cause, the first approach is usually lowering the antipsychotic dose or switching to a medication with a gentler receptor profile. If those changes aren’t possible, a common add-on treatment is a low-dose beta blocker, which has been shown to be more effective for this specific problem than anti-anxiety medications. Anticholinergic medications and benzodiazepines are also used as alternatives.
For walking driven by psychomotor agitation, the priority is treating the underlying psychotic episode. As delusions and hallucinations come under control, the urge to pace typically diminishes on its own. Stereotypic walking is the hardest to address, since it reflects a deeper neurological pattern that doesn’t always respond predictably to medication adjustments.
The practical takeaway is that excessive walking in someone with schizophrenia is almost always a signal, not a quirk. It points to either undertreated psychosis, a medication side effect, or a neurological pattern worth evaluating. Identifying which one is driving the behavior changes what happens next and how effectively it can be resolved.